Literature DB >> 21886721

Herpes zoster - associated erythema multiforme.

Uwe Wollina1, Astrid Gemmeke.   

Abstract

BACKGROUND: Erythema multiforme is a cutaneous reaction that has only rarely been described in varicella zoster virus infection. MAIN OBSERVATIONS: We describe a 76-year old immunocompetent male patient with thoracic herpes zoster. While treated with oral brivudin he developed a widespread cutaneous erythema multiforme. The lesions completely cleared with two weeks with systemic corticosteroids.
CONCLUSION: Varicella zoster infections are possible triggers of erythema multiforme and this is the oldest patient reported with such an association. Brivudin itself has not been reported to induce erythema multiforme and is an unlikely cause of disease in our patient.

Entities:  

Keywords:  brivudin; drug reaction; erythema multiforme; varicella zoster virus; virus diseases

Year:  2009        PMID: 21886721      PMCID: PMC3157789          DOI: 10.3315/jdcr.2009.1025

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  8 in total

1.  Erythema multiforme after resolution of herpes zoster by acyclovir.

Authors:  Ikuko Onishi; Saburo Kishimoto
Journal:  Eur J Dermatol       Date:  2002 Jul-Aug       Impact factor: 3.328

2.  Localization of perforin in viral vesicles and erythema multiforme.

Authors:  K Sayama; Y Watanabe; M Tohyama; Y Miki
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

3.  Varicella zoster virus infection associated with erythema multiforme in children.

Authors:  D Prais; G Grisuru-Soen; A Barzilai; J Amir
Journal:  Infection       Date:  2001 Jan-Feb       Impact factor: 3.553

Review 4.  Erythema multiforme.

Authors:  Michele R Lamoreux; Marna R Sternbach; W Teresa Hsu
Journal:  Am Fam Physician       Date:  2006-12-01       Impact factor: 3.292

Review 5.  Brivudin (bromovinyl deoxyuridine).

Authors:  Susan J Keam; Therese M Chapman; David P Figgitt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Bullous erythema multiforme following herpes zoster and varicella-zoster virus infection.

Authors:  K Weisman; C S Petersen; C W Blichmann; N H Nielsen; B M Hultberg
Journal:  J Eur Acad Dermatol Venereol       Date:  1998-09       Impact factor: 6.166

7.  Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.

Authors:  Pietro Quaglino; Marzia Caproni; Emiliano Antiga; Elena Del Bianco; Simona Osella-Abate; Paola Savoia; Alessandra Frezzolini; Donatella Schena; Angelo Marzano; Walter Volpi; Clara De Simone; Aurora Parodi; Paolo Fabbri; Maria Grazia Bernengo
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

8.  Herpes zoster guideline of the German Dermatology Society (DDG).

Authors:  G Gross; H Schöfer; S Wassilew; K Friese; A Timm; R Guthoff; H W Pau; J P Malin; P Wutzler; H W Doerr
Journal:  J Clin Virol       Date:  2003-04       Impact factor: 3.168

  8 in total
  6 in total

1.  A case of erythema multiforme followed by herpes zoster.

Authors:  I H Park; J N Kang; J E Seol; H S Sung; H Kim
Journal:  Infection       Date:  2014-04-24       Impact factor: 3.553

Review 2.  [Herpes zoster and postherpetic neuralgia].

Authors:  U Wollina; J Machetanz
Journal:  Hautarzt       Date:  2016-08       Impact factor: 0.751

3.  Herpes zoster in pregnancy leading to keloids and post herpetic neuralgia: A double whammy?

Authors:  Shyam B Verma; Uwe Wollina
Journal:  Indian Dermatol Online J       Date:  2013-04

Review 4.  Variations in herpes zoster manifestation.

Authors:  Uwe Wollina
Journal:  Indian J Med Res       Date:  2017-03       Impact factor: 2.375

Review 5.  Herpes zoster: A Review of Clinical Manifestations and Management.

Authors:  Anant Patil; Mohamad Goldust; Uwe Wollina
Journal:  Viruses       Date:  2022-01-19       Impact factor: 5.048

6.  Herpes Zoster with disseminated lesions. What is it?

Authors:  S Gupta; S Gupta; M Thomas; A Mahendra; N Jindal; G Bhaskar; M Aggarwal
Journal:  J Med Life       Date:  2013-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.